$ROKU Oversold - Buy the Blood
This is the most oversold this stock has been since the pandemic market lows of March 2020. I'm expecting a bounce here sometime in the next week. Great company with solid earnings. This selloff is overdone in my opinion. Avg analyst price target is about $408 right now, with vast majority giving it a Buy rating.
Near term target: $275-$300 range possible by year-end
Note: This is NOT investment advice. Educational only.
This is the most oversold this stock has been since the pandemic market lows of March 2020. I'm expecting a bounce here sometime in the next week. Great company with solid earnings. This selloff is overdone in my opinion. Avg analyst price target is about $408 right now, with vast majority giving it a Buy rating.
Near term target: $275-$300 range possible by year-end
Note: This is NOT investment advice. Educational only.